Fusarium rhinosinusitis post chimeric antigen receptor T-cell therapy

Chimeric antigen receptor T-cell (CAR-T) therapy is a novel treatment for various types of hematologic malignancy. We presented a case of refractory diffuse large B cell lymphoma patient who developed acute invasive fungal rhinosinusitis (AIFR) from Fusarium species after CAR-T therapy. Our photos i...

Full description

Bibliographic Details
Main Authors: Supavit Chesdachai, Natalia E. Castillo Almeida, Isin Y. Comba, Prasuna Muppa, Matthew J. Thoendel
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:IDCases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214250921000445
_version_ 1818613428449705984
author Supavit Chesdachai
Natalia E. Castillo Almeida
Isin Y. Comba
Prasuna Muppa
Matthew J. Thoendel
author_facet Supavit Chesdachai
Natalia E. Castillo Almeida
Isin Y. Comba
Prasuna Muppa
Matthew J. Thoendel
author_sort Supavit Chesdachai
collection DOAJ
description Chimeric antigen receptor T-cell (CAR-T) therapy is a novel treatment for various types of hematologic malignancy. We presented a case of refractory diffuse large B cell lymphoma patient who developed acute invasive fungal rhinosinusitis (AIFR) from Fusarium species after CAR-T therapy. Our photos illustrated the classic clinical, endoscopic, and histopathologic findings of AIFR.
first_indexed 2024-12-16T16:01:58Z
format Article
id doaj.art-79968d4784dc4fd2bddfb87b4ea6e4ee
institution Directory Open Access Journal
issn 2214-2509
language English
last_indexed 2024-12-16T16:01:58Z
publishDate 2021-01-01
publisher Elsevier
record_format Article
series IDCases
spelling doaj.art-79968d4784dc4fd2bddfb87b4ea6e4ee2022-12-21T22:25:26ZengElsevierIDCases2214-25092021-01-0124e01088Fusarium rhinosinusitis post chimeric antigen receptor T-cell therapySupavit Chesdachai0Natalia E. Castillo Almeida1Isin Y. Comba2Prasuna Muppa3Matthew J. Thoendel4Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA; Corresponding author at: Division of Infectious Diseases, Department of Medicine, 200 First Street SW, Rochester, MN, 55905, USA.Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USADivision of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USADepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USADivision of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA; Corresponding author at: Division of Infectious Diseases, Department of Medicine, 200 First Street SW, Rochester, MN, 55905, USA.Chimeric antigen receptor T-cell (CAR-T) therapy is a novel treatment for various types of hematologic malignancy. We presented a case of refractory diffuse large B cell lymphoma patient who developed acute invasive fungal rhinosinusitis (AIFR) from Fusarium species after CAR-T therapy. Our photos illustrated the classic clinical, endoscopic, and histopathologic findings of AIFR.http://www.sciencedirect.com/science/article/pii/S2214250921000445Chimeric antigen receptorNeutropeniaInvasive fungal rhinosinusitisFusarium
spellingShingle Supavit Chesdachai
Natalia E. Castillo Almeida
Isin Y. Comba
Prasuna Muppa
Matthew J. Thoendel
Fusarium rhinosinusitis post chimeric antigen receptor T-cell therapy
IDCases
Chimeric antigen receptor
Neutropenia
Invasive fungal rhinosinusitis
Fusarium
title Fusarium rhinosinusitis post chimeric antigen receptor T-cell therapy
title_full Fusarium rhinosinusitis post chimeric antigen receptor T-cell therapy
title_fullStr Fusarium rhinosinusitis post chimeric antigen receptor T-cell therapy
title_full_unstemmed Fusarium rhinosinusitis post chimeric antigen receptor T-cell therapy
title_short Fusarium rhinosinusitis post chimeric antigen receptor T-cell therapy
title_sort fusarium rhinosinusitis post chimeric antigen receptor t cell therapy
topic Chimeric antigen receptor
Neutropenia
Invasive fungal rhinosinusitis
Fusarium
url http://www.sciencedirect.com/science/article/pii/S2214250921000445
work_keys_str_mv AT supavitchesdachai fusariumrhinosinusitispostchimericantigenreceptortcelltherapy
AT nataliaecastilloalmeida fusariumrhinosinusitispostchimericantigenreceptortcelltherapy
AT isinycomba fusariumrhinosinusitispostchimericantigenreceptortcelltherapy
AT prasunamuppa fusariumrhinosinusitispostchimericantigenreceptortcelltherapy
AT matthewjthoendel fusariumrhinosinusitispostchimericantigenreceptortcelltherapy